A new medical development is sweeping the country…

Some may see it as controversial – but the studies don't lie.

It's effective.

So effective, in fact, that the FDA has just fast-tracked approval for research…

Meaning that it is aiming to gain a major stake in a key healthcare market that is on track to hit $260 billion in the next six years.

And one company, in particular, is making lots of right moves.

In the last 13 months, Champignon Brands (CN:SHRM;OTC:SHRMF) has taken a potential wonder drug from concept to product production for medical research. It then went public as a company and gained controlling ownership of a leading medical treatment clinic.

The name of this potential wonder drug is psilocybin, a natural psychedelic compound found in mushrooms, and it could very well end up saving the life of someone you love.